Toward a COVID-19 Testing Policy: Where and How to Test When the Purpose Is to Isolate Silent Spreaders

preprint OA: closed
🔓 Open OA copy View at publisher
AI-generated summary by claude@2026-07, 2026-07-17

This study evaluated geo-referenced data, cost-benefit analysis, and temporal mortality or test positivity (TP) to determine optimal COVID-19 testing policies, finding that low TP correlates with fewer deaths and cost-effective targeted testing.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: To stop pandemics, such as COVID-19, infected individuals should be detected, treated if needed, and –to prevent contacts with susceptible individuals− isolated. Because most infected individuals may be asymptomatic, when testing misses such cases, epidemics may growth exponentially, inducing a high number of deaths. In contrast, a relatively low number of COVID-19 related deaths may occur when both symptomatic and asymptomatic cases are tested.Methods: To evaluate these hypotheses, a method composed of three elements was evaluated, which included: (i) county- and country-level geo-referenced data, (ii) cost-benefit related considerations, and (iii) temporal data on mortality or test positivity (TP). TP is the percentage of infections found among tested individuals. Temporal TP data were compared to the tests/case ratio (T/C ratio) as well as the number of tests performed/million inhabitants (tests/mi) and COVID-19 related deaths/million inhabitants (deaths/mi).Findings: Two temporal TP profiles were distinguished, which, early, displayed low (~ 1%) and/or decreasing TP percentages or the opposite pattern, respectively. Countries that exhibited >10 TP % expressed at least ten times more COVID-19 related deaths/mi than low TP countries. An intermediate pattern was identified when the T/C ratio was explored. Geo-referenced, TP-based analysis discovered municipalities where selective testing would be more cost-effective than alternatives.Interpretations: When TP is low and/or the T/C ratio is high, testing detects asymptomatic cases and the number of COVID-19 related deaths/mi is low. Geo-referenced TP data can support cost-effective, site-specific policies. TP promotes the prompt cessation of epidemics and fosters science-based testing policies.Funding Statement: None.Declaration of Interests: We declare no competing interests.Ethics Approval Statement: No primary data were collected for this study, which used publicly available data.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00